ARIBA INC Spending and interest coverage
- R&D / revenue · 12 months: Value 13.33%; Formula and calculation Research and development expense / revenue. Period ending 2012-06-30..
- Stock-based compensation / revenue · 12 months: Value 13.91%; Formula and calculation Share-based compensation / revenue. Period ending 2012-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2012-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 13.33% | Research and development expense / revenue. Period ending 2012-06-30. $68.92M ÷ $516.83M × 100 ≈ 13.33% |
| Stock-based compensation / revenue · 12 months | 13.91% | Share-based compensation / revenue. Period ending 2012-06-30. $71.91M ÷ $516.83M × 100 ≈ 13.91% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 68.92M USD | Research and Development Expense |
| Revenue | 516.83M USD | |
| Stock-based compensation | 71.91M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 11.15M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2012-06-30 | $68.92M | $516.83M | $71.91M | $11.15M | (m) | 13.33% | 13.91% | (m) | (m) |
| 2012-03-31 | $67.26M | $501.78M | $67.13M | $-2.46M | (m) | 13.40% | 13.38% | (m) | (m) |
| 2011-12-31 | $64.55M | $479.08M | $63.31M | $-7.72M | (m) | 13.47% | 13.21% | (m) | (m) |
| 2011-09-30 | $60.47M | $443.85M | $57.88M | $-4.43M | (m) | 13.62% | 13.04% | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $51.05M | $367.08M | $49.95M | $11.80M | (m) | 13.91% | 13.61% | (m) | (m) |
| 2010-12-31 | $47.39M | $335.63M | $46.56M | (m) | (m) | 14.12% | 13.87% | (m) | (m) |
| 2010-09-30 | $46.04M | $320.40M | $46.83M | $15.11M | (m) | 14.37% | 14.62% | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | $43.48M | $285.70M | $32.65M | $8.37M | (m) | 15.22% | 11.43% | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | $52.27M | $328.06M | $40.86M | $-48.68M | (m) | 15.93% | 12.45% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.